TITLE:
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

CONDITION:
Rheumatoid Arthritis

INTERVENTION:
Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)

SUMMARY:

      The purpose of this clinical research study is to learn if Abatacept or Infliximab in
      combination with Methotrexate demonstrate a greater reduction in disease activity over
      placebo.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  Diagnosis of Rheumatoid Arthritis

          -  At least 3 months prior treatment with Methotrexate (MTX)

          -  At least 10 swollen joints and 12 tender joints and C-Reactive Protein of at least 1
             mg/dl

          -  Washout required for other disease modifying anti-rheumatic drugs (DMARDS)

        Exclusion Criteria:

          -  participants who have failed more than 3 DMARDs

          -  participants previously treated with an approved biologic drug

          -  History of cancer in the last 5 years

          -  Severe or recurrent bacterial infection

          -  Any previous or current medical conditions that are contraindications to the use of
             TNF blocking agents

          -  Women of Child Bearing Potential
      
